Targeted cancer therapies have significantly improved survival outcomes for lung cancer patients. GEFTIB Tablets are a widely used oral targeted therapy for specific types of lung cancer. At Unnati Pharmax, we specialize in the export of GEFTIB from India, supplying high-quality pharmaceutical products to international markets.
This blog provides complete information about GEFTIB uses, benefits, mechanism of action, dosage, side effects, and export availability.
What is GEFTIB?
GEFTIB contains Gefitinib, a tyrosine kinase inhibitor (TKI) used in the treatment of non-small cell lung cancer (NSCLC). It works by blocking the epidermal growth factor receptor (EGFR), which plays a key role in cancer cell growth.
Because of its targeted mechanism, GEFTIB is effective in patients with EGFR mutation–positive lung cancer.
Uses of GEFTIB Tablets
GEFTIB Tablets are mainly prescribed for:
-
Non-small cell lung cancer (NSCLC)
-
EGFR mutation–positive lung cancer
-
Advanced or metastatic lung cancer
-
Patients who are not suitable for chemotherapy
Therefore, GEFTIB is an important option in modern lung cancer treatment.
How Does GEFTIB Work?
GEFTIB blocks the EGFR tyrosine kinase enzyme.
As a result:
-
Cancer cell growth slows down
-
Tumor spread is reduced
-
Cancer cell survival decreases
This targeted action helps control the disease with fewer side effects compared to traditional chemotherapy.
Dosage and Administration
-
Recommended dose: One tablet once daily
-
Taken orally with water
-
Can be taken with or without food
⚠️ Important: Dosage should be determined by an oncologist based on the patient’s condition.
Possible Side Effects
Some patients may experience mild to moderate side effects, such as:
-
Skin rash
-
Diarrhea
-
Nausea
-
Loss of appetite
-
Fatigue
-
Dry skin
However, most side effects are manageable with proper medical supervision.
Precautions and Warnings
Before taking GEFTIB, patients should inform their doctor if they have:
-
Liver problems
-
Lung infections or breathing issues
-
Pregnancy or breastfeeding plans
Additionally, regular monitoring is recommended during treatment.
Why Choose Unnati Pharmax for GEFTIB Export?
Unnati Pharmax is a reliable pharmaceutical exporter from India, known for quality assurance and global compliance.
Our Key Advantages
-
WHO-GMP certified manufacturers
-
Competitive export pricing
-
Secure export packaging
-
Complete export documentation
-
Reliable worldwide delivery
As a result, international buyers trust Unnati Pharmax for oncology medicine supply.
Global Export of GEFTIB Tablets
Unnati Pharmax exports GEFTIB Tablets to:
-
Africa
-
Middle East
-
Southeast Asia
-
CIS countries
-
Latin America
Moreover, we provide regulatory and logistics support for smooth import clearance.
Frequently Asked Questions (FAQs)
1. What is GEFTIB used for?
GEFTIB is used to treat EGFR-positive non-small cell lung cancer.
2. Is GEFTIB chemotherapy?
No. GEFTIB is a targeted therapy, not traditional chemotherapy.
3. Can GEFTIB be exported from India?
Yes. Unnati Pharmax exports GEFTIB with full legal and regulatory documentation.
4. How should GEFTIB be stored?
Store at room temperature, away from moisture and direct sunlight.
5. Why buy GEFTIB from Unnati Pharmax?
Because we offer authentic medicines, export expertise, and reliable global supply.
Conclusion
In conclusion, GEFTIB Tablets are an effective targeted therapy for the treatment of advanced non-small cell lung cancer. Choosing a trusted exporter ensures product quality and uninterrupted supply.
